Sort   by:  
 Page size 
UnknownSafety and tolerability of conditioning chemotherapy followed by CD19-targeted CAR T cells for relapsed/refractory CLL.
Not available
S-EPMC6538317 | biostudies-literature
UnknownDelayed Sequential Co-Delivery of Gefitinib and Doxorubicin for Targeted Combination Chemotherapy.
Not available
S-EPMC5714665 | biostudies-literature
UnknownLipopolysaccharide-specific memory B cell responses to an attenuated live cholera vaccine are associated with protection against Vibrio cholerae infection.
Not available
S-EPMC5922764 | biostudies-literature
UnknownThe Effects of Acutely Administered 3,4-Methylenedioxymethamphetamine on Spontaneous Brain Function in Healthy Volunteers Measured with Arterial Spin Labeling and Blood Oxygen Level-Dependent Resting State Functional Connectivity.
Not available
S-EPMC4578244 | biostudies-literature
UnknownNaturally Occurring Fusarium Species and Mycotoxins in Oat Grains from Manitoba, Canada.
Not available
S-EPMC8473195 | biostudies-literature
UnknownAutologous CD19-Targeted CAR T Cells in Patients with Residual CLL following Initial Purine Analog-Based Therapy.
Not available
S-EPMC6094824 | biostudies-literature
UnknownDepletion of high-content CD14+ cells from apheresis products is critical for successful transduction and expansion of CAR T cells during large-scale cGMP manufacturing.
Not available
S-EPMC8411225 | biostudies-literature
UnknownConcurrent therapy of chronic lymphocytic leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia utilizing CD19-targeted CAR T-cells.
Not available
S-EPMC6037308 | biostudies-literature
UnknownPreventing recurrence in Sonic Hedgehog Subgroup Medulloblastoma using the OLIG2 inhibitor CT-179.
Not available
S-EPMC10275055 | biostudies-literature
UnknownSuppressing recurrence in Sonic Hedgehog subgroup medulloblastoma using the OLIG2 inhibitor CT-179.
Not available
S-EPMC11794477 | biostudies-literature
Sort   by:  
 Page size